0001752724-21-140698.txt : 20210628 0001752724-21-140698.hdr.sgml : 20210628 20210628135500 ACCESSION NUMBER: 0001752724-21-140698 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20210430 FILED AS OF DATE: 20210628 PERIOD START: 20210731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LORD ABBETT DEVELOPING GROWTH FUND, INC. CENTRAL INDEX KEY: 0000276914 IRS NUMBER: 132958970 STATE OF INCORPORATION: MD FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-02871 FILM NUMBER: 211052170 BUSINESS ADDRESS: STREET 1: 90 HUDSON ST. CITY: JERSEY CITY STATE: NJ ZIP: 07302 BUSINESS PHONE: 201-827-2000 MAIL ADDRESS: STREET 1: 90 HUDSON ST. CITY: JERSEY CITY STATE: NJ ZIP: 07302 FORMER COMPANY: FORMER CONFORMED NAME: LORD ABBETT DEVELOPING GROWTH FUND INC /NEW/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DEVELOPING GROWTH SHARES INC DATE OF NAME CHANGE: 19600201 0000276914 S000006834 LORD ABBETT DEVELOPING GROWTH FUND INC C000018473 Class A LAGWX C000018475 Class C LADCX C000018476 Class P LADPX C000018477 Class I LADYX C000054855 Class F LADFX C000054856 Class R2 LADQX C000054857 Class R3 LADRX C000151972 Class R4 LADSX C000151973 Class R5 LADTX C000151974 Class R6 LADVX C000188220 Class F3 LOGWX NPORT-P 1 primary_doc.xml NPORT-P false 0000276914 XXXXXXXX S000006834 C000188220 C000018475 C000151974 C000151972 C000054856 C000151973 C000018473 C000018476 C000018477 C000054857 C000054855 LORD ABBETT DEVELOPING GROWTH FUND, INC. 811-02871 0000276914 549300HWJ2W28SDTJF85 90 HUDSON ST. JERSEY CITY 07302 201-827-2000 LORD ABBETT DEVELOPING GROWTH FUND INC S000006834 549300HWJ2W28SDTJF85 2021-07-31 2021-04-30 N 5456160621.79 62325656.10 5393834965.69 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N AZEK Co Inc/The N/A AZEK Co Inc/The 05478C105 1171087.00000000 NS USD 56540080.36000000 1.048235267108 Long EC CORP US N 1 N N N Penn National Gaming Inc N/A Penn National Gaming Inc 707569109 384053.00000000 NS USD 34226803.36000000 0.634554145199 Long EC CORP US N 1 N N N Sonos Inc 549300WEPU6075I77M08 Sonos Inc 83570H108 2595231.00000000 NS USD 103887096.93000000 1.926034029421 Long EC CORP US N 1 N N N Upwork Inc N/A Upwork Inc 91688F104 1021252.00000000 NS USD 47038867.12000000 0.872085768645 Long EC CORP US N 1 N N N DigitalOcean Holdings Inc 549300EPISPY3RE3DL21 DigitalOcean Holdings Inc 25402D102 525214.00000000 NS USD 22883573.98000000 0.424254248147 Long EC CORP US N 1 N N N DoubleVerify Holdings Inc N/A DoubleVerify Holdings Inc 25862V105 445519.00000000 NS USD 15686723.99000000 0.290826917949 Long EC CORP US N 1 N N N Fidelity Investments 549300FQDFZGLUOCWN51 Fidelity Investments Money Market Government Portfolio 31607A703 47532938.00000000 NS USD 47532938.00000000 0.881245687017 Long STIV RF US N 1 N N Redfin Corp 549300HXWD3JEMZU3O57 Redfin Corp 75737F108 592100.00000000 NS USD 41908838.00000000 0.776976645866 Long EC CORP US N 1 N N N SI-BONE Inc 549300J8JGYVJJHV9C31 SI-BONE Inc 825704109 977529.00000000 NS USD 34702279.50000000 0.643369322953 Long EC CORP US N 1 N N N Trex Co Inc N/A Trex Co Inc 89531P105 425938.00000000 NS USD 45997044.62000000 0.852770707902 Long EC CORP US N 1 N N N Cerence Inc 5493002WL2W5WMS89568 Cerence Inc 156727109 313918.00000000 NS USD 30264834.38000000 0.561100489216 Long EC CORP US N 1 N N N Altra Industrial Motion Corp NQ0NIXPGW4YKG4MWM571 Altra Industrial Motion Corp 02208R106 879124.00000000 NS USD 51877107.24000000 0.961785215342 Long EC CORP US N 1 N N N Hydrofarm Holdings Group Inc 5493005Y60YG0W2FYJ83 Hydrofarm Holdings Group Inc 44888K209 707153.00000000 NS USD 46459952.10000000 0.861352866662 Long EC CORP US N 1 N N Repligen Corp 54930006QJ0T5AUO1E71 Repligen Corp 759916109 122461.00000000 NS USD 25926218.31000000 0.480663914912 Long EC CORP US N 1 N N N Fiverr International Ltd 549300Z8OREY6THCPF67 Fiverr International Ltd 000000000 118431.00000000 NS USD 24641938.17000000 0.456853765952 Long EC CORP IL N 1 N N N Semtech Corp 549300J7WUY317SW6O61 Semtech Corp 816850101 920210.00000000 NS USD 62335025.40000000 1.155671721447 Long EC CORP US N 1 N N N CEVA Inc 529900G9T7CVU2J2VU73 CEVA Inc 157210105 1009338.00000000 NS USD 55957698.72000000 1.037438095083 Long EC CORP US N 1 N N N Planet Fitness Inc 549300LLE5HUPF6H8G33 Planet Fitness Inc 72703H101 664436.00000000 NS USD 55805979.64000000 1.034625271165 Long EC CORP US N 1 N N N Pacific Biosciences of California Inc N/A Pacific Biosciences of California Inc 69404D108 900227.00000000 NS USD 26871775.95000000 0.498194255495 Long EC CORP US N 1 N N N Berkeley Lights Inc 549300LTLRE4N65CD358 Berkeley Lights Inc 084310101 255704.00000000 NS USD 12557623.44000000 0.232814380118 Long EC CORP US N 1 N N N Axonics Inc 549300LJY4X7N57VJL05 Axonics Inc 05465P101 1493203.00000000 NS USD 93967264.79000000 1.742123468510 Long EC CORP US N 1 N N N Acceleron Pharma Inc 529900TQRID2UY164805 Acceleron Pharma Inc 00434H108 411239.00000000 NS USD 51392537.83000000 0.952801451229 Long EC CORP US N 1 N N N Helen of Troy Ltd N/A Helen of Troy Ltd 000000000 204959.00000000 NS USD 43289390.39000000 0.802571651994 Long EC CORP BM N 1 N N N Balchem Corp 549300VR70OPMHUI3557 Balchem Corp 057665200 340795.00000000 NS USD 43345716.05000000 0.803615911975 Long EC CORP US N 1 N N N National Vision Holdings Inc 549300JHURCBLI5ROA42 National Vision Holdings Inc 63845R107 1281977.00000000 NS USD 64624460.57000000 1.198117127814 Long EC CORP US N 1 N N N Globant SA 2221008DCMSPYS42DS88 Globant SA 000000000 279694.00000000 NS USD 64100270.92000000 1.188398816940 Long EC CORP LU N 1 N N N Inari Medical Inc N/A Inari Medical Inc 45332Y109 790020.00000000 NS USD 90291385.80000000 1.673973830759 Long EC CORP US N 1 N N N At Home Group Inc 549300LGPR0P05O30I24 At Home Group Inc 04650Y100 871581.00000000 NS USD 27524527.98000000 0.510296072369 Long EC CORP US N 1 N N N Latham Group Inc N/A Latham Group Inc 51819L107 1229936.00000000 NS USD 31978336.00000000 0.592868269114 Long EC CORP US N 1 N N N Fox Factory Holding Corp 529900GE1HSV0617R721 Fox Factory Holding Corp 35138V102 266007.00000000 NS USD 40760252.61000000 0.755682234797 Long EC CORP US N 1 N N N Tempur Sealy International Inc 549300HFEKVR3US71V91 Tempur Sealy International Inc 88023U101 1957382.00000000 NS USD 74654549.48000000 1.384071814485 Long EC CORP US N 1 N N N Evoqua Water Technologies Corp 529900YQAOMEZRGRRP43 Evoqua Water Technologies Corp 30057T105 1795245.00000000 NS USD 51308102.10000000 0.951236039411 Long EC CORP US N 1 N N N Intellia Therapeutics Inc 5493002T5BCPE5DZC723 Intellia Therapeutics Inc 45826J105 601815.00000000 NS USD 46201337.55000000 0.856558234426 Long EC CORP US N 1 N N N Turning Point Therapeutics Inc N/A Turning Point Therapeutics Inc 90041T108 499430.00000000 NS USD 38071548.90000000 0.705834515556 Long EC CORP US N 1 N N N Amyris Inc 549300BG17WCUK6EIM58 Amyris Inc 03236M200 3079361.00000000 NS USD 44835496.16000000 0.831235965601 Long EC CORP US N 1 N N N Silvergate Capital Corp BPE6FTXDZEBNAGIT2T19 Silvergate Capital Corp 82837P408 572905.00000000 NS USD 61426874.10000000 1.138834882615 Long EC CORP US N 1 N N N Inspire Medical Systems Inc 549300XQQCQ7HCJKTW25 Inspire Medical Systems Inc 457730109 544262.00000000 NS USD 128892126.84000000 2.389619401777 Long EC CORP US N 1 N N N Generac Holdings Inc 529900S2H2AHJHSFFI84 Generac Holdings Inc 368736104 164713.00000000 NS USD 53358776.35000000 0.989254893585 Long EC CORP US N 1 N N N Sunrun Inc 54930007SJ77CI66U531 Sunrun Inc 86771W105 807915.00000000 NS USD 39587835.00000000 0.733945981881 Long EC CORP US N 1 N N N Western Alliance Bancorp 5493003VJXZ5JXT9S762 Western Alliance Bancorp 957638109 1023114.00000000 NS USD 107498587.98000000 1.992989935060 Long EC CORP US N 1 N N N Olo Inc N/A Olo Inc 68134L109 454611.00000000 NS USD 13120073.46000000 0.243242026192 Long EC CORP US N 1 N N Axon Enterprise Inc 549300QP2IEEGFE16681 Axon Enterprise Inc 05464C101 597707.00000000 NS USD 90618358.27000000 1.680035797283 Long EC CORP US N 1 N N N Iovance Biotherapeutics Inc 549300220Z2GHH33XL82 Iovance Biotherapeutics Inc 462260100 962053.00000000 NS USD 30246946.32000000 0.560768850222 Long EC CORP US N 1 N N N Nevro Corp 254900SH91I4BOYKUE38 Nevro Corp 64157F103 207942.00000000 NS USD 35934457.02000000 0.666213505763 Long EC CORP US N 1 N N N Shake Shack Inc 529900J74GJAHYP80N79 Shake Shack Inc 819047101 340959.00000000 NS USD 37079291.25000000 0.687438371508 Long EC CORP US N 1 N N N Blackline Inc 529900P9N7PK9LV5EK56 Blackline Inc 09239B109 230462.00000000 NS USD 26747419.72000000 0.495888730191 Long EC CORP US N 1 N N N RealReal Inc/The 549300O00VUGT4H1PE90 RealReal Inc/The 88339P101 1559194.00000000 NS USD 38621235.38000000 0.716025529621 Long EC CORP US N 1 N N N Mirati Therapeutics Inc 529900GYRW59IDQV6N54 Mirati Therapeutics Inc 60468T105 229195.00000000 NS USD 38096792.90000000 0.706302531359 Long EC CORP US N 1 N N N Calix Inc 5299002RQRZ4SXSCSJ58 Calix Inc 13100M509 1873641.00000000 NS USD 79236277.89000000 1.469015614938 Long EC CORP US N 1 N N N Marriott Vacations Worldwide Corp 549300WA6BT5H4F7IO94 Marriott Vacations Worldwide Corp 57164Y107 225673.00000000 NS USD 40086294.99000000 0.743187272969 Long EC CORP US N 1 N N N Magnite Inc 54930018FR2YX1HHSB02 Magnite Inc 55955D100 662052.00000000 NS USD 26515182.60000000 0.491583127193 Long EC CORP US N 1 N N N Eventbrite Inc 549300N6XBV2B1FAUF55 Eventbrite Inc 29975E109 1269101.00000000 NS USD 29912710.57000000 0.554572224776 Long EC CORP US N 1 N N N Intra-Cellular Therapies Inc 5299002U2KGF193IJA20 Intra-Cellular Therapies Inc 46116X101 1520464.00000000 NS USD 52349575.52000000 0.970544628320 Long EC CORP US N 1 N N N Westport Fuel Systems Inc 549300ZBKJ4TMPXRB502 Westport Fuel Systems Inc 960908309 4493674.00000000 NS USD 30691793.42000000 0.569016175230 Long EC CORP CA N 1 N N Shift4 Payments Inc N/A Shift4 Payments Inc 82452J109 1059351.00000000 NS USD 104759220.39000000 1.942202923455 Long EC CORP US N 1 N N N Krystal Biotech Inc 549300YONUY68210OE41 Krystal Biotech Inc 501147102 897215.00000000 NS USD 71274759.60000000 1.321411575500 Long EC CORP US N 1 N N N Diodes Inc 549300XP2X1ARVH3BX23 Diodes Inc 254543101 878123.00000000 NS USD 67448627.63000000 1.250476294863 Long EC CORP US N 1 N N N Olink Holding AB 8945004Z7ZHV3LML4J27 Olink Holding AB 680710100 358301.00000000 NS USD 12612195.20000000 0.233826123346 Long EC CORP SE N 1 N N Fixed Income Clearing Corp 549300H47WTHXPU08X20 FIXED INC CLEARING CORP.REPO 000000000 54168221.21000000 PA USD 54168221.21000000 1.004261746133 Long RA CORP US N 2 Repurchase N 0.00000000 2021-05-03 56171400.00000000 USD 55251628.71298200 USD UST N N N LGI Homes Inc 549300W02B4WNV8CV109 LGI Homes Inc 50187T106 658011.00000000 NS USD 109085063.58000000 2.022402692590 Long EC CORP US N 1 N N N Karuna Therapeutics Inc N/A Karuna Therapeutics Inc 48576A100 205959.00000000 NS USD 22863508.59000000 0.423882242141 Long EC CORP US N 1 N N N Crocs Inc 549300B0J6YCXD63OG72 Crocs Inc 227046109 956725.00000000 NS USD 95787307.00000000 1.775866477363 Long EC CORP US N 1 N N N NanoString Technologies Inc 549300G4CK0Y3WRDMY89 NanoString Technologies Inc 63009R109 415784.00000000 NS USD 33125511.28000000 0.614136537189 Long EC CORP US N 1 N N N Everbridge Inc 549300WCY0UMR64ATW81 Everbridge Inc 29978A104 207895.00000000 NS USD 27589745.45000000 0.511505183705 Long EC CORP US N 1 N N N Rush Enterprises Inc 529900V3XHTN7A6DFT17 Rush Enterprises Inc 781846209 1105857.00000000 NS USD 54585101.52000000 1.011990575670 Long EC CORP US N 1 N N N Lumentum Holdings Inc 549300JLWRRC38DWEF52 Lumentum Holdings Inc 55024U109 317127.00000000 NS USD 26971651.35000000 0.500045913928 Long EC CORP US N 1 N N N Quanterix Corp N/A Quanterix Corp 74766Q101 759823.00000000 NS USD 46455578.22000000 0.861271776305 Long EC CORP US N 1 N N N Citibank NA E57ODZWZ7FF32TWEFA76 CITIBANK NA DDCA 000000000 5281438.00000000 NS USD 5281438.00000000 0.097916195686 Long STIV RF US N 1 N N Littelfuse Inc 549300MY7HLQFYTPCX75 Littelfuse Inc 537008104 212659.00000000 NS USD 56405673.16000000 1.045743399988 Long EC CORP US N 1 N N N Blueprint Medicines Corp 5299004CC60O9T5HVM83 Blueprint Medicines Corp 09627Y109 396969.00000000 NS USD 38236054.08000000 0.708884389737 Long EC CORP US N 1 N N N CareDx Inc 549300NQOFKL9NON0U06 CareDx Inc 14167L103 993782.00000000 NS USD 78578342.74000000 1.456817704654 Long EC CORP US N 1 N N N Bridgebio Pharma Inc 54930028YG89VTY2J114 Bridgebio Pharma Inc 10806X102 947793.00000000 NS USD 53000584.56000000 0.982614130709 Long EC CORP US N 1 N N N MacroGenics Inc 5493001KJQUA83L8MH79 MacroGenics Inc 556099109 1246977.00000000 NS USD 40352175.72000000 0.748116617892 Long EC CORP US N 1 N N N YETI Holdings Inc 549300DSQICIGNT5GO63 YETI Holdings Inc 98585X104 892537.00000000 NS USD 76240510.54000000 1.413475032605 Long EC CORP US N 1 N N N Open Lending Corp N/A Open Lending Corp 68373J104 1449682.00000000 NS USD 56610082.10000000 1.049533077302 Long EC CORP US N 1 N N N Shockwave Medical Inc 549300LDXO56IC5Y1538 Shockwave Medical Inc 82489T104 590417.00000000 NS USD 96509562.82000000 1.789256872594 Long EC CORP US N 1 N N N TG Therapeutics Inc 529900X21UKABN9NJ529 TG Therapeutics Inc 88322Q108 1718410.00000000 NS USD 76830111.10000000 1.424406041132 Long EC CORP US N 1 N N N Endava PLC 213800JJ6CRPCWCQVZ25 Endava PLC 29260V105 841934.00000000 NS USD 76228704.36000000 1.413256149750 Long EC CORP GB N 1 N N N Malibu Boats Inc N/A Malibu Boats Inc 56117J100 943261.00000000 NS USD 78630236.96000000 1.457779807134 Long EC CORP US N 1 N N N MKS Instruments Inc 549300KEQATBHAGVF505 MKS Instruments Inc 55306N104 519819.00000000 NS USD 93104781.09000000 1.726133292587 Long EC CORP US N 1 N N N Ultragenyx Pharmaceutical Inc 529900EV44GVDN1DCX77 Ultragenyx Pharmaceutical Inc 90400D108 335422.00000000 NS USD 37446512.08000000 0.694246529940 Long EC CORP US N 1 N N N Insmed Inc 529900Q55QAG41CCAC11 Insmed Inc 457669307 1769611.00000000 NS USD 59688979.03000000 1.106614855843 Long EC CORP US N 1 N N N Cardlytics Inc 549300JETJBH94EIPC66 Cardlytics Inc 14161W105 652560.00000000 NS USD 89746576.80000000 1.663873243636 Long EC CORP US N 1 N N N RH 5493008MTS3OGGMHGK69 RH 74967X103 146228.00000000 NS USD 100607788.56000000 1.865236685956 Long EC CORP US N 1 N N Brooks Automation Inc 35ZN6X1ANPH25YN32Y17 Brooks Automation Inc 114340102 699437.00000000 NS USD 70873951.21000000 1.313980714293 Long EC CORP US N 1 N N N Natera Inc N/A Natera Inc 632307104 898154.00000000 NS USD 98814903.08000000 1.831997154317 Long EC CORP US N 1 N N N ON24 Inc N/A ON24 Inc 68339B104 334677.00000000 NS USD 14725788.00000000 0.273011467604 Long EC CORP US N 1 N N N Jamf Holding Corp N/A Jamf Holding Corp 47074L105 903149.00000000 NS USD 32983001.48000000 0.611494450419 Long EC CORP US N 1 N N N Rapid7 Inc 549300GNVG5D60KEYN14 Rapid7 Inc 753422104 654524.00000000 NS USD 53180075.00000000 0.985941826887 Long EC CORP US N 1 N N N Sprout Social Inc N/A Sprout Social Inc 85209W109 898451.00000000 NS USD 59558316.79000000 1.104192419101 Long EC CORP US N 1 N N N Inmode Ltd N/A Inmode Ltd 000000000 634806.00000000 NS USD 54802801.98000000 1.016026673574 Long EC CORP IL N 1 N N N TPI Composites Inc 549300TI9H56OIY0QE39 TPI Composites Inc 87266J104 497984.00000000 NS USD 26467849.60000000 0.490705588294 Long EC CORP US N 1 N N N Lightspeed POS Inc 254900T8MDWRTGMFZ257 Lightspeed POS Inc 53227R106 569364.00000000 NS USD 39747300.84000000 0.736902428287 Long EC CORP CA N 1 N N N Arena Pharmaceuticals Inc 529900CVGQMPJ3A3NI85 Arena Pharmaceuticals Inc 040047607 588569.00000000 NS USD 40393490.47000000 0.748882580333 Long EC CORP US N 1 N N N Trupanion Inc 549300J86GFKIDGMQP18 Trupanion Inc 898202106 345070.00000000 NS USD 27985177.00000000 0.518836359992 Long EC CORP US N 1 N N N Rocket Pharmaceuticals Inc 549300R7VV82YUIN4Y93 Rocket Pharmaceuticals Inc 77313F106 1055264.00000000 NS USD 48373301.76000000 0.896825766225 Long EC CORP US N 1 N N N Deckers Outdoor Corp 5493008LG4W3I6K8J118 Deckers Outdoor Corp 243537107 196076.00000000 NS USD 66312903.20000000 1.229420321938 Long EC CORP US N 1 N N N Five9 Inc 254900MXP6EWY0SFFR59 Five9 Inc 338307101 381185.00000000 NS USD 71651344.45000000 1.328393339910 Long EC CORP US N 1 N N N Freshpet Inc 549300S4ZK8ZQ6HNPN59 Freshpet Inc 358039105 281004.00000000 NS USD 51935159.28000000 0.962861481865 Long EC CORP US N 1 N N N Chart Industries Inc EM7QGKC1GYOF3LSZSL80 Chart Industries Inc 16115Q308 580076.00000000 NS USD 93177607.88000000 1.727483478317 Long EC CORP US N 1 N N N Digital Turbine Inc 549300D0WZR1VI2QGB24 Digital Turbine Inc 25400W102 821762.00000000 NS USD 61985507.66000000 1.149191772723 Long EC CORP US N 1 N N N Q2 Holdings Inc 549300M9RKR9DZXWS696 Q2 Holdings Inc 74736L109 255102.00000000 NS USD 26535710.04000000 0.491963699460 Long EC CORP US N 1 N N N Appian Corp 529900NIARIFW7HGU386 Appian Corp 03782L101 269614.00000000 NS USD 32671824.52000000 0.605725327671 Long EC CORP US N 1 N N SunPower Corp 549300TXO070764WUH65 SunPower Corp 867652406 1220665.00000000 NS USD 31358883.85000000 0.581383821519 Long EC CORP US N 1 N N 2021-05-28 LORD ABBETT DEVELOPING GROWTH FUND, INC. Vito Fronda Vito Fronda Treasurer XXXX GRAPHIC 2 x2_c101859x1x1.jpg begin 644 x2_c101859x1x1.jpg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end NPORT-EX 3 NPORT_EBX8_3985161493.htm

 

Lord Abbett

Quarterly Portfolio Holdings Report

 

Lord Abbett
Developing Growth Fund

 

For the period ended April 30, 2021

 

Schedule of Investments (unaudited)

April 30, 2021

 

Investments  Shares   Fair
Value
(000)
 
COMMON STOCKS 98.65%        
         
Aerospace & Defense 1.68%        
Axon Enterprise, Inc.*   597,707   $90,618 
           
Auto Components 0.76%          
Fox Factory Holding Corp.*   266,007    40,760 
           
Banks 3.13%          
Silvergate Capital Corp. Class A*   572,905    61,427 
Western Alliance Bancorp   1,023,114    107,498 
Total        168,925 
           
Biotechnology 16.23%          
Acceleron Pharma, Inc.*   411,239    51,393 
Arena Pharmaceuticals, Inc.*   588,569    40,393 
Blueprint Medicines Corp.*   396,969    38,236 
Bridgebio Pharma, Inc.*   947,793    53,001 
CareDx, Inc.*   993,782    78,578 
Insmed, Inc.*   1,769,611    59,689 
Intellia Therapeutics, Inc.*   601,815    46,201 
Iovance Biotherapeutics, Inc.*    962,053    30,247 
Karuna Therapeutics, Inc.*   205,959    22,863 
Krystal Biotech, Inc.*   880,811    69,972 
MacroGenics, Inc.*   1,246,977    40,352 
Mirati Therapeutics, Inc.*   273,837    45,517 
Natera, Inc.*   898,154    98,815 
Rocket Pharmaceuticals, Inc.*   1,055,264    48,373 
TG Therapeutics, Inc.*   1,718,410    76,830 
Turning Point Therapeutics, Inc.*   499,430    38,072 
Ultragenyx Pharmaceutical, Inc.*   335,422    37,447 
Total        875,979 
           
Building Products 1.90%          
AZEK Co., Inc. (The)*   1,171,087    56,540 
Trex Co., Inc.*   425,938    45,997 
Total        102,537 
Investments  Shares   Fair
Value
(000)
 
Capital Markets 1.05%        
Open Lending Corp. Class A*   1,449,682   $56,610 
           
Chemicals 1.63%          
Amyris, Inc.*   3,079,361    44,835 
Balchem Corp.   340,795    43,346 
Total        88,181 
           
Communications Equipment 1.97%          
Calix, Inc.*   1,873,641    79,236 
Lumentum Holdings, Inc.*   317,127    26,972 
Total        106,208 
           
Electrical Equipment 2.00%          
Generac Holdings, Inc.*   164,713    53,359 
Sunrun, Inc.*   577,582    28,301 
TPI Composites, Inc.*   497,984    26,468 
Total        108,128 
           
Electronic Equipment, Instruments & Components 1.04%
Littelfuse, Inc.   212,659    56,406 
           
Food Products 0.96%          
Freshpet, Inc.*   281,004    51,935 
           
Health Care Equipment & Supplies 7.52%          
Axonics, Inc.*   1,493,203    93,967 
Inari Medical, Inc.*   790,020    90,291 
Inmode Ltd. (Israel)*(a)   634,806    54,803 
Nevro Corp.*   207,942    35,935 
Shockwave Medical, Inc.*   590,417    96,510 
SI-BONE, Inc.*   977,529    34,702 
Total        406,208 
           
Health Care Technology 2.39%          
Inspire Medical Systems, Inc.*   544,262    128,892 
           
Hotels, Restaurants & Leisure 3.10%          
Marriott Vacations Worldwide Corp.*   225,673    40,086 
Penn National Gaming, Inc.*   384,053    34,227 


 

  See Notes to Schedule of Investments. 1
 

Schedule of Investments (unaudited)(continued)

April 30, 2021

 

Investments  Shares   Fair
Value
(000)
 
Hotels, Restaurants & Leisure (continued)          
Planet Fitness, Inc. Class A*   664,436   $55,806 
Shake Shack, Inc. Class A*   340,959    37,079 
Total        167,198 
           
Household Durables 5.84%          
Helen of Troy Ltd.*   129,660    27,385 
LGI Homes, Inc.*   658,011    109,085 
Sonos, Inc.*   2,595,231    103,887 
Tempur Sealy International, Inc.   1,957,382    74,655 
Total        315,012 
           
Information Technology Services 4.96%          
Digitalocean Holdings, Inc.*   525,214    22,884 
Endava plc ADR*   841,934    76,229 
Globant SA (Argentina)*(a)   279,694    64,100 
Shift4 Payments, Inc. Class A*   1,059,351    104,759 
Total        267,972 
           
Insurance 0.52%          
Trupanion, Inc.*   345,070    27,985 
           
Interactive Media & Services 0.55%          
Eventbrite, Inc. Class A*   1,269,101    29,913 
           
Internet & Direct Marketing Retail 1.66%          
Fiverr International Ltd. (Israel)*(a)   118,431    24,642 
Magnite, Inc.*   662,052    26,515 
RealReal, Inc. (The)*   1,559,194    38,621 
Total        89,778 
           
Internet Software & Services 1.66%          
Cardlytics, Inc.*   652,560    89,747 
           
Leisure Equipment & Products 0.59%          
Latham Group, Inc.*   1,229,936    31,978 
           
Leisure Products 2.87%          
Malibu Boats, Inc. Class A*   943,261    78,630 
YETI Holdings, Inc.*   892,537    76,241 
Total        154,871 
Investments  Shares   Fair
Value
(000)
 
Life Sciences Tools & Services 2.92%          
Berkeley Lights, Inc.*   255,704   $12,558 
NanoString Technologies, Inc.*     415,784    33,125 
Olink Holding AB ADR*(b)   358,301    12,612 
Pacific Biosciences of California, Inc.*   900,227    26,872 
Quanterix Corp.*   759,823    46,456 
Repligen Corp.*   122,461    25,926 
Total        157,549 
           
Machinery 5.07%          
Altra Industrial Motion Corp.   879,124    51,877 
Chart Industries, Inc.*   580,076    93,178 
Evoqua Water Technologies Corp.*   1,795,245    51,308 
Hydrofarm Holdings Group, Inc.*(b)   707,153    46,460 
Westport Fuel System, Inc. (Canada)*(a)(b)   4,493,674    30,692 
Total        273,515 
           
Pharmaceuticals 0.97%          
Intra-Cellular Therapies, Inc.*   1,520,464    52,350 
           
Professional Services 0.87%          
Upwork, Inc.*   1,021,252    47,039 
           
Real Estate Management & Development 0.78%          
Redfin Corp.*   592,100    41,909 
           
Semiconductors & Semiconductor Equipment 6.98%
Brooks Automation, Inc.   699,437    70,874 
CEVA, Inc.*   1,009,338    55,958 
Diodes, Inc.*   878,123    67,449 
MKS Instruments, Inc.   519,819    93,105 
Semtech Corp.*   920,210    62,335 
SunPower Corp.*(b)   1,047,395    26,907 
Total        376,628 


 

2 See Notes to Schedule of Investments.
 

Schedule of Investments (unaudited)(continued)

April 30, 2021

 

Investments  Shares   Fair
Value
(000)
 
Software 9.43%          
Appian Corp.*(b)   269,614   $32,672 
Blackline, Inc.*   230,462    26,747 
Cerence, Inc.*   313,918    30,265 
Digital Turbine, Inc.*   821,762    61,986 
DoubleVerify Holdings, Inc.*   524,193    18,457 
Everbridge, Inc.*   207,895    27,590 
Five9, Inc.*   381,185    71,651 
Jamf Holding Corp.*   903,149    32,983 
Lightspeed POS, Inc. (Canada)*(a)   569,364    39,747 
Olo, Inc. Class A*(b)   454,611    13,120 
ON24, Inc.*   334,677    14,726 
Q2 Holdings, Inc.*   255,102    26,536 
Rapid7, Inc.*   654,524    53,180 
Sprout Social, Inc. Class A*   898,451    59,558 
Total        509,218 
           
Specialty Retail 3.61%          
At Home Group, Inc.*   938,834    29,648 
National Vision Holdings, Inc.*   1,281,977    64,625 
RH*(b)   146,228    100,608 
Total        194,881 
           
Textiles, Apparel & Luxury Goods 3.00%          
Crocs, Inc.*   956,725    95,787 
Deckers Outdoor Corp.*   196,076    66,313 
Total        162,100 
           
Trading Companies & Distributors 1.01%          
Rush Enterprises, Inc. Class A   1,105,857    54,585 
Total Common Stocks
(cost $3,811,743,897)
        5,325,615 
Investments  Principal
Amount
(000)
   Fair
Value
(000)
 
SHORT-TERM INVESTMENTS 1.98%          
           
Repurchase Agreement 1.00%          
Repurchase Agreement dated 4/30/2021, 0.00% due 5/3/2021 with Fixed Income Clearing Corp. collateralized by $56,171,400 of U.S. Treasury Note at 0.375% due 11/30/2025 value: $55,251,629; proceeds: $54,168,221
(cost $54,168,221)
  $54,168   $54,168 
           
    Shares      
           
Money Market Fund 0.88%          
Fidelity Government Portfolio(c)
(cost $47,532,938)
   47,532,938    47,533 
           
Time Deposit 0.10%          
CitiBank N.A.(c)
(cost $5,281,438)
   5,281,438    5,281 
Total Short-Term Investments
(cost $106,982,597)
        106,982 
Total Investments in Securities 100.63%
(cost $3,918,726,494)
        5,432,597 
Liabilities in Excess of  Other Assets (0.63)%    (34,080)
Net Assets 100.00%       $5,398,517 

 

ADR   American Depositary Receipt.
*   Non-income producing security.
(a)   Foreign security traded in U.S. dollars.
(b)   All or a portion of this security is temporarily on loan to unaffiliated broker/dealers.
(c)   Security was purchased with the cash collateral from loaned securities.


 

  See Notes to Schedule of Investments. 3
 

Schedule of Investments (unaudited)(concluded)

April 30, 2021

 

The following is a summary of the inputs used as of April 30, 2021 in valuing the Fund’s investments carried at fair value(1):

 

Investment Type(2)  Level 1
(000)
   Level 2
(000)
   Level 3
(000)
   Total
(000)
 
Common Stocks  $5,325,615   $   $   $5,325,615 
Short-Term Investments                    
Repurchase Agreement       54,168        54,168 
Money Market Fund   47,533            47,533 
Time Deposit       5,281        5,281 
Total  $5,373,148   $59,449   $   $5,432,597 
     
(1)   Refer to Note 2(b) for a description of fair value measurements and the three-tier hierarchy of inputs.
(2)   See Schedule of Investments for fair values in each industry and identification of foreign issuers and/or geography.
     
    A reconciliation of Level 3 investments is presented when the Fund has a material amount of Level 3 investments at the beginning or end of the period in relation to the Fund’s net assets.

 

4 See Notes to Schedule of Investments.
 

Notes to Schedule of Investments (unaudited)

 

1. ORGANIZATION  

 

Lord Abbett Developing Growth Fund, Inc. (the “Fund”) is registered under the Investment Company Act of 1940, as amended (the “Act”), as a diversified, open-end management investment company. The Fund was incorporated under Maryland law on August 21, 1978. The Fund’s predecessor corporation was organized on July 11, 1973.

 

2. SIGNIFICANT ACCOUNTING POLICIES  

 

(a) Investment Valuation-Under procedures approved by the Fund’s Board of Directors (the “Board”), Lord, Abbett & Co. LLC (“Lord Abbett”), the Fund’s investment manager, has formed a Pricing Committee to administer the pricing and valuation of portfolio investments and to ensure that prices utilized reasonably reflect fair value. Among other things, these procedures allow the Fund to utilize independent pricing services, quotations from securities and financial instrument dealers and other market sources to determine fair value.
   
  Securities actively traded on any recognized U.S. or non-U.S. exchange or on The NASDAQ Stock Market LLC are valued at the last sale price or official closing price on the exchange or system on which they are principally traded. Events occurring after the close of trading on non-U.S. exchanges may result in adjustments to the valuation of foreign securities to reflect their fair value as of the close of regular trading on the New York Stock Exchange. The Fund may utilize an independent fair valuation service in adjusting the valuations of foreign securities. Unlisted equity securities are valued at the last quoted sale price or, if no sale price is available, at the mean between the most recently quoted bid and asked prices.
   
  Securities for which prices are not readily available are valued at fair value as determined by the Pricing Committee. The Pricing Committee considers a number of factors, including observable and unobservable inputs, when arriving at fair value. The Pricing Committee may use related or comparable assets or liabilities, recent transactions, market multiples, book values and other relevant information to determine the fair value of portfolio investments. The Board or a designated committee thereof regularly reviews fair value determinations made by the Pricing Committee and may employ techniques such as reviewing related market activity, reviewing inputs and assumptions, and retrospectively comparing prices of subsequent purchases and sales transactions to fair value determinations made by the Pricing Committee.
   
  Short-term securities with 60 days or less remaining to maturity are valued using the amortized cost method, which approximates fair value.
   
(b) Fair Value Measurements-Fair value is defined as the price that the Fund would receive upon selling an investment or transferring a liability in an orderly transaction to an independent buyer in the principal or most advantageous market of the investment. A three-tier hierarchy is used to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk - for example, the risk inherent in a particular valuation technique used to measure fair value (such as a pricing model) and/or the risk inherent in the inputs to the valuation technique. Inputs may be observable or unobservable. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability. Observable inputs are based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the reporting entity’s own

 

5

 

Notes to Schedule of Investments (unaudited)(continued)

 

assumptions about the assumptions market participants would use in pricing the asset or liability. Unobservable inputs are based on the best information available in the circumstances. The three-tier hierarchy classification is determined based on the lowest level of inputs that is significant to the fair value measurement, and is summarized in the three broad Levels listed below:

 

  Level 1 –  unadjusted quoted prices in active markets for identical investments;
       
  Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.); and
       
  Level 3 – significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments).

 

  A summary of inputs used in valuing the Fund’s investments as of April 30, 2021 and, if applicable, Level 3 rollforwards for the period then ended is included in the Fund’s Schedule of Investments.
   
  Changes in valuation techniques may result in transfers into or out of an assigned level within the three-tier hierarchy. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

 

3. FEDERAL TAX INFORMATION  

 

It is the policy of the Fund to meet the requirements of Subchapter M of the Internal Revenue Code applicable to regulated investment companies and to distribute substantially all taxable income and capital gains to its shareholders. Therefore, no income tax provision is required.

 

The Fund files U.S. federal and various state and local tax returns. No income tax returns are currently under examination. The statute of limitations on the Fund’s filed U.S. federal tax returns remains open generally three years after the filing of the tax return. The statutes of limitations on the Fund’s, state and local tax returns may remain open for an additional year depending upon the jurisdiction.

 

4. SECURITIES LENDING AGREEMENT  

 

The Fund has established a securities lending agreement with Citibank, N.A. (the “agent”) for the lending of securities to qualified brokers in exchange for securities or cash collateral equal to at least the market value of securities loaned, plus interest, if applicable. Cash collateral is invested in an approved money market fund. In accordance with the Fund’s securities lending agreement, the market value of securities on loan is determined each day at the close of business and any additional collateral required to cover the value of securities on loan is delivered to the Fund on the next business day. As with other extensions of credit, the Fund may experience a delay in the recovery of its securities or incur a loss should the borrower of the securities breach its agreement with the Fund or become insolvent at a time when the collateral is insufficient to cover the cost of repurchasing securities on loan.

 

The initial collateral received by the Fund is required to have a value equal to at least 100% of the market value of the securities loaned. The collateral must be marked-to-market daily to cover increases in the market value of the securities loaned (or potentially a decline in the value of the collateral). In general, the risk of borrower default will be borne by the Fund’s agent; the Fund will bear the risk of loss with respect to the investment of the cash collateral. The advantage of such

 

6

 

Notes to Schedule of Investments (unaudited)(concluded)

 

loans is that the Fund continues to receive income on loaned securities while receiving a portion of any securities lending fees and earning returns on the cash amounts which may be reinvested for the purchase of investments in securities.

 

As of April 30, 2021, the market value of securities loaned and collateral received for the Fund was as follows:

 

Market Value of      
Securities Loaned   Collateral Received  
$ 50,169,248   $ 52,814,376  

 

7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

QPHR-DEV-3Q

(4/21)